Publications

1. Lans M., de Gerlache J., Taper H., Préat V. and Roberfroid M.
   Phenobarbital as a promoter in the initiation/selection process of rat hepatocarcinogenesis.
   Carcinogenesis, 4, 141-144 (1983)
   
2. Préat V., Pector J. Cl., Taper H., Lans M., de Gerlache J. and Roberfroid M.
   Promoting effect of portocaval anastomosis in rat hepatocarcinogenesis.
   Carcinogenesis, 5, 1151-1154 (1984)
   
3. Préat V., Pector J.Cl, Taper H., de Gerlache J., Lans M., Roberfroid M.
   Effet promoteur de l'anastomose portocave dans l'hépatocancérogenèse expérimentale.
   C.R. Soc. Biol., 178, 408-413 (1984)
   
4. Lans M., de Gerlache J., Préat V., Taper H., Roberfroid M.
   Analyse systémique comparative de modèles expérimentaux de cancérogenèse hépatique induite chimiquement chez le rat.
   C.R.Soc. Biol., 178, 397-407 (1984)
   
5. de Gerlache J., Lans M., Préat V., Taper H. and Roberfroid M.
   Comparison of different models of rat liver carcinogenesis : conclusions from a systemic analysis.
   Toxicologic Pathology, 12, 374-382 (1984)
   
6. Préat V., de Gerlache J., Lans M., Taper H. and Roberfroid M.
   Influence of the nature and the dose of the initiator on the development of premalignant and malignant lesions in rat hepatocarcinogenesis.
   Teratog. Carcinog. Mutag., 6, 165-172 (1986)
   
7. Préat V., de Gerlache J., Lans M., Taper H. and Roberfroid M.
   Comparative analysis of the effect of phenobarbital, dichloro-diphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis.
   Carcinogenesis, 7, 1025-1028 (1986)
   
8. Préat V., Lans M., de Gerlache J., Taper H. and Roberfroid M.
   Comparison of the biological effect of phenobarbital and nafenopin on rat hepatocarcinogenesis.
   Gann, 77, 629-638 (1986)
   
9. Préat V., de Gerlache J., Lans M. and Roberfroid M.
   Promoting effects of oxazepam in rat hepatocarcinogenesis.
   Carcinogenesis, 8, 97-100 (1987)
   
10. Préat V., Lans M., de Gerlache J., Taper H. and Roberfroid M.
    Influence of the duration and the delay of administration of phenobarbital on its modulating effect on rat hepatocarcinogenesis.
    Carcinogenesis, 8, 333-335 (1987)
    
11. de Gerlache J., Taper H., Lans M., Préat V. and Roberfroid M.
    Dietary modulation of rat liver carcinogenesis.
    Carcinogenesis, 8, 337-340 (1987).
    
12. Deleener A., Castelain P., Préat V., de Gerlache J., Alexandre H. and Kirch-Volders M.
    Changes in nucleolar transcriptional activity and nuclear DNA content during the first steps of rat hepatocarcinogenesis.
    Carcinogenesis, 8, 195-201 (1987)
    
13. Préat V., Schulze C., Sterzel W., Eisenbrand G. and Roberfroid M.
    Comparison of induction of DNA single strand breaks and initiation of rat hepatocarcinogenesis by different nitrosamines.
    IARC Scientific Publications on N-Nitroso-compounds, 84, 200-201 (1987)
    
14. Harris L., Préat V. and Farber E.
    Patterns of ligand binding to normal, regeneration, preneoplastic and neoplastic rat hepatocytes.
    Cancer Research, 47, 3954-3958 (1987)
    
15. Haesen S., Derijke T., Deleener A., Castelain Ph., Alexandre H., Préat V. and Kirsch-Volders M.
    The influence of phenobarbital and butylated hydroxytoluene on the ploidy rate in rat hepatocarcinogenesis.
    Carcinogenesis, 9, 1755-1761 (1988)
    
16. Bartsch H., Préat V., Aitio A., Cabral J R and Roberfroid M.
    Partial hepatectomy of rats ten weeks before carcinogen administration can enhance liver carcinogenesis : preliminary observations.
    Carcinogenesis, 9, 2315-2317 (1988)
    
17. Tasset Ch., Goethals F., Préat V. and Roland M.
    Effect of polyoxyethyleneglycol (24) cholesterol on the solubility, toxicity and activity of amphotericin B.
    Int J.Pharm., 58, 41-48 (1990)
    
18. Abdellatif A., Préat V., Vamecq J., Nilsson R., and Roberfroid M.
    Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2, 4, 5 trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin.
    Carcinogenesis, 11, 1899-1902 (1990)
    
19. Roberfroid M. and Préat V.
    Modulation of neoplastic development : concepts and examples.
    Bulletin du Cancer, 77, 467-473 (1990)
    
20. Gaspar R., Préat V. and Roland M.
    Nanoparticles of polyisohexylcyanoacrylate (P.I.H.C.A.) as a carrier of primaquine: formulation, physicochemical characterization and acute toxicity.
    Int.J. Pharm., 68, 111-119 (1991)
    
21. Tasset Ch., Préat V. and Roland M.
    The influence of Myrj 59 on the solubilité, toxicity and activity of amphotericin B
    J. Pharm.Pharmacol., 43,297-302(1991)
    
22. Roberfroid M., Delzenne N. and Préat V.
    Modulation of hepatocarcinogenesis
    Annu. Rev. Pharmacol. Toxicol., 31, 163-175 (1991)
    
23. Nilson R., Beije B., Préat V., Erixon K. and Ramel C.
    On the mechanism of the hepatocarcinogenicity of peroxisome proliferators.
    Chem. Biol. Interactions, 78, 235-250 (1991)
    
24. Schwarze PE, Saeter G., Armstrong D., Cameron R., Laconi E., Sarma D., Préat V. and Seglen P.
    Diploid growth pattern of hepatocellular tumors induced by various carcinogenic treatments.
    Carcinogenesis, 12, 325-327 (1991)
    
25. Marino A, Ravelingien N., De Cannière D, Préat V, Dehaye J.P. and Pector,
    Adenylate cyclase activity in crude liver membranes during chemical hepatocarcinogenesis.
    Carcinogenesis,12, 659-664 (1991)
    
26. Préat V.
    Modulation of liver carcinogenesis.
    Recent Results in Cancer Res. 122, 9-15, (1991)
    
27. Abdellatif A., Préat V., Taper H. and Roberfroid M.
    The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator.
    Tox. Appl. Pharm., 111, 530-537, (1991)
    
28. De Cannière D., Ravelingien N., Préat V., Delhaye J.P. and Pector J.C.
    Adenylate cyclase activity in crude liver membranes during chemical hepatocarcinogenesis in portacaval shunted rats.
    Carcinogenesis, 13,241-246, (1992)
    
29. Thysman S., Préat V. and Roland M.
    Factors affecting iontophoretic mobility of metoprolol.
    J. Pharm.Sc., 81, 670-675 (1992)
    
30. Gaspar R., Préat V., Opperdoes F. and Roland M.
    Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leismania donovani associated with hydrogen peroxide production.
    Pharm. Res., 9,782-787 (1992)
    
31. Gaspar R, Opperdoes F, Préat V and Roalnd M.
    Drug targetting with polyalkylcyanoacrylate nanoparticles : in vitro activity of primaquine loaded nanoparticles against intracellular Leishmania donovani.
    Annals of Tropical Medicine and Parasitology, 86, 41-49 (1992)
    
32. Tasset Ch., Préat V., Bernard A. and Roland M.
    Comparison of nephrotoxicities of different Polyoxyethyleneglycol. formulations of amphotericin B in Rats.
    Antimicrobial Agents and Chemotherapy,.36, 1525-1531 (1992)
    
33. Tasset Ch., Préat V. and Roland M.
    Comparison of the in vivo antifungal activity of Amphotericin B-SolutanC24, Amphotericin B-Myrj 59 and AmphotericinB-Synperonic A50 with Fungizone.
    Int. J. Pharm., 81, R5-R9 (1992)
    
34. Tasset C., Préat V. and Roland M.
    Clinical formulations of amphotericin B.
    J. Pharm. de Belgique, 47, 523-536 (1992)
    
35. Préat V.and Thysman S.
    Transdermal iontophoretic delivery of sufentanil.
    Int. J. Pharm., 96, 189-196 (1993)
    
36. Thysman S. and Préat V.
    In vivo iontophoresis of fentanyl and sufentanil in rats : pharmacokinetics and acute antinociceptive effects.
    Anesth.Analg. 77, 61-66 (1993)
    
37. Thysman S., Tasset Ch. and Préat V.
    Transdermal iontophoretis of fentanyl : delivery and mechanistic analysis.
    Int J. Pharm, 101, 105-113 (1994)
    
38. Thysman S, Hanchard C. and Préat V.
    Human calcitonin delivery in rats by iontophoresis.
    J. Pharm Pharmacol, 46, 725-730 (1994)
    
39. Vanbever R., Lecouturier N. and Préat V.
    Transdermal delivery of metoprolol by electroporation.
    Pharm. Res., 11, 1657-1662 (1994)
    
40. Tasset Ch., Barette N., Thysman S., Ketelslegers J.M., Lemoine D. and Préat V.
    Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin.
    J. Controlled Release, 33, 23-30 (1995)
    
41. Thysman S., Van Neste D. and Préat V.
    Non invasive investigation of human skin after in vivo iontophoresis.
    Skin Pharmacology, 8, 229-236 (1995)
    
42. Jadoul A., Hanchard C., Thysman S. and Préat V.
    Quantification and localization of fentanyl and TRH delivered by iontophoresis in the skin.
    Int.J.Pharm., 120, 221-228 (1995)
    
43. Vanbever R.and Préat V.
    Factors affecting transdermal delivery of metoprolol by electroporation.
    Bioelectrochemistry.and Bioenergetics., 38, 223-228 (1995)
    
44. Thysman S., Jadoul A., Leroy T., Van Neste D. and Préat V.
    Laser doppler evaluation of skin reaction in volunteers after histamine iontophoresis.
    J. Controlled Release, 36, 215-219 (1995)
    
45. Leroy TH., Jadoul A., Thysman S., Préat V. and Van Neste D.
    In vivo laser doppler evaluation of specific histamine-agonist effects in the skin.
    J. European Academy of Dermatology and Venereology, 5, S134 (1995)
    
46. Jadoul A., Mesens J., Caers W., de Beukelaar F., Crabbé R. and Préat V.
    Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetic data.
    Pharm.Res, 13, 1348-1353 (1996)
    
47. Vanbever R., Leboulengé E. and Préat V.
    Transdermal delivery of fentanyl by electroporation I Influence of electrical factors.
    Pharm. Res.13, 559-565 (1996)
    
48. Lemoine D., François C., Kedzierewicz F., Préat V., Hoffman M. and Maincent Ph.
    Stability study of nanoparticles of poly (epsilon-caprolactone), poly(D,L-lactide) and poly (D,L-lactide-co-glycolide)
    Biomaterials, 17, 2191-2197 (1996)
    
49. Vanbever R., De Morre N. and Préat V.
    Transdermal delivery of fentanyl by electroporation II mechanisms involved in drug transport.
    Pharm. Res., 13, 1360-1366 (1996)
    
50. Jadoul A., Doucet J., Durand D. and préat V.
    Modifications induced on stratum corneum structure after in vitro iontophoresis: ATR-FTIR and X-ray scattering studies.
    J. Controlled Release, 42,165-173 (1996)
    
51. Vanbever R., Prausnitz M. and Préat V.
    Macromolecules enhance transdermal mannitol permeation by skin electroporation.
    Pharm Res.14, 639-644 (1997)
    
52. Jadoul A. and Préat V.
    Electrically enhanced transdermal delivery of domperidone.
    Int. J. Pharm, 154, 229-234 (1997)
    
53. Jadoul A., Regnier V., Doucet J., Durand D. and Préat V.
    X-ray scattering analysis of human stratum corneum treated by high voltage pulses
    Pharm.Res., 14, 1275-1277(1997)
    
54. Vanbever R., Langers G., S. Montmayeur and Préat V.
    Transdermal delivery of fentanyl. Rapid onset of analgesia using skin electroporation.
    J.Controlled Release,50, 225-235 (1998)
    
55. Vanbever R, Leroy M.A. and Préat V.
    Transdermal permeation of neutral molecules by skin electroporation.
    J.Controlled release,54, 243-250 (1998)
    
56. Jadoul A., Tanajo H., Préat V., Bouwstra J.A., Spies F. and Boddé H.
    Electroperturbation of human stratum corneum fine structure by high voltage pulses: a freeze fracture electron microscopy and differential thermal analysis study.
    J.Investigative Dermatology Symposium Proc, 3, 153-158 (1998)
    
57. Regnier V. Le Doan T. and Préat V.
    Parameters controlling topical delivery of oligonucleotides by electroporation.
    J. Drug targeting, 5, 275-289 (1998)
    
58. Lemoine D., M.Francotte and Préat V.
    Nasal vaccines : from fundamental concepts to vaccine development.
    STP Pharma Sciences, special issue Mucosal Immunisation, 8, 5-18 (1998)
    
59. Lemoine D. and Préat V.
    Polymeric nanoparticles as delivery system for influenza virus glycoproteins.
    J.Controlled Release, 54, 15-27 (1998)
    
60. Vanbever R., Fouchard D., Jadoul A., De Morre N., Préat V.and Marty J.P.
    In vivo non-invasive evaluation of hairless rat skin after high-voltage pulse exposure.
    Skin Pharmacol Appl, 11, 23-34 (1998)
    
61. Jadoul A., Lecouturier N., Mesens J., Caers W. and Préat V.
    Transdermal alnitidan delivery by skin electroporation.
    J. Controlled Release, 54, 265-272 (1998)
    
62. Regnier V., and Préat V.
    Localization of FITC labelled phosphorothioate oligonucleotides in the skin after topical delivery by iontophoresis and electroporation.
    Pharm.Res., 15, 1596-1602 (1998)
    
63. Lemoine D. Wauters F., Bouchend’homme S. and Préat V.
    Preparation and characterization of alginate microspheres containing a model antigen.
    Int.J.Pharm,176, 9-19 (1998)
    
64. Préat V.
    Augmentation of transdermal drug penetration
    Bulletin et Mémoires de l’Académie Royale de Médecine de Belgique, 153, 5-6 (1998)
    
65. Pliquett U., Vanbever R., Préat V. and Weaver J.
    Local transport regions (LTRs) in human stratum corneum due to long and short ‘high voltage’ pulses
    Bioelectrochemistry and bioeneergetics 47, 151-161 (1998)
    
66. Clarys P., Alewaeters K., Jadoul A., Barel A., Oliveira Manadas R. and Préat V.
    In vitro percutaneous penetration through hairless rat skin ; influence of temperature, vehicle and penetration enhancers
    Eur. J. Pharmaceutics and Biopharmaceutics, 46 279-283 (1998)
    
67. Préat V. and Prausnitz M.
    Enhanced drug delivery using high voltage pulses (Preface to a special issue)
    Adv. Drug Del. Rev., 35, 1-2 (1999)
    
68. Jadoul A., Bouwstra J. and Préat V.
    Effects of iontophoresis and electroporation on the stratum corneum Review of the biophysical studies.
    Adv.Drug Del.Rev., 35, 89-105 (1999)
    
69. Préat V. and Vanbever R.
    In vivo efficacy and safety of skin electroporation.
    Adv. Drug Del. Rev., 35, 77-88 (1999)
    
70. Regnier V., De Morre N., Jadoul A. and Préat V.
    Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation.
    Int.J.Pharm, 184, 147-156 (1999)
    
71. Vanbever R., Pliquett U., Préat V. and Weaver J.
    Comparison of the effects of short, high-voltage and long, medium-voltage pulses on skin electrical and transport properties.
    J.Controlled Release, 60, 35-47 (1999)
    
72. Lemoine D., Deschuyteneer M., Hogge F. and Préat V.
    Intranasal immunisation against influenza virus using polylmeric particles
    J.Biomater. Sci. Polymer Edn, 10, 805-825 (1999)
    
73. Regnier V., Tahiri A., André N., Lemaître M., LeDoan T. and Préat V.
    Electroporation mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin.
    J.Controlled Release, 67, 337-346 (2000)
    
74. Lombry C.,Dujardin N. and Préat V.
    Influence of molecular weight on transdermal drug delivery by skin electroporation
    Pharm.Res.,17, 32-37 (2000)
    
75. Dujardin N., Van der Smissen P. and Préat V.
    Topical Gene transfer into rat skin by electroporation
    Pharm.Res, 18, 61-66 (2001)
    
76. Préat V. and Dujardin N.
    Topical delivery of nucleic acids in the skin
    STP Pharma Sc, 11, 57-68 (2001)
    
77. Bosquillon C., Lombry C., Préat V. and Vanbever R.,
    Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolisation performance,
    J.Controlled Release, 70, 329-339 (2001)
    
78. Bosquillon C., Lombry C., Préat V. and Vanbever R.,
    Comparison of particle sizing techniques in the case of inhalation dry powders,
    J. Pharm. Sc., 90, 2032-2041 (2001)
    
79. Mathy F.X., Préat V. and Verbeeck R.
    Validation of subcutaneous microdialysis sampling for pharmacokinetic studies of flurbiprofen in the rat.
    J. Pharma. Sc., 90, 1897-1906 (2001)
    
80. Mathy FX., Préat V. and Verbeeck R.K.
    Validation of subcutaneous microdialysis sampling for pharmacokinetic studies of flurbiprofen in the rat.
    J. Pharm.Sc., 90, 1897-1906 (2001)
    
81. Préat V.
    Drug and gene delivery using electrotransfer.
    Annales Pharmaceutiques Françaises, 59, 239-244 (2001)
    
82. Dujardin N., Staes E., Kalia Y., Clarys P., Guy R. and Préat V.
    In vivo assessment of skin electroporation using square wave pulses.
    J.Controlled Release, 79, 219-227 (2002)
    
83. Lombry C., Bosquillon C., Préat V. and Vanbever R.
    Confocal imaging of rat lungs following intracheal delivery of dry powders or solutions of fluroescent probes
    J. Controlled Release, 83, 331-341 (2002)
    
84. Denet A.-R., Préat V.,
    Transdermal delivery of timolol by electroporation through human skin,
    Journal of Controlled Release, 88, 253-262 (2003)
    
85. Mathy F.-X., Denet A.-R., Vroman B., Barel A., Verbeeck R.-K., Préat V.
    In vivo tolerance Assessment of skin after Insertion of subcutaneous and cutaneous microdialysis Probes in the Rat.,
    Skin Pharmacology and Applied. Skin Physiol., 16, 18-27 (2003)
    
86. Mathy F.-X., Vroman B., Ntivunwa D., De Winne A., Verbeeck R.-K., Préat V. On-line determination of fluconazole in blood and dermal rat microdialysates by microbore high performance liquid chromatography ,
    Journal of Chromatography, 787, 323-331 (2003)
    
87. Codrons V., Vanderbist F., Verbeeck R.-K., Arras M., Lison D., Préat V.,Vanbever R.
    Systemic Delivery of Parathyroid Hormone (1-34) Using Inhalation Dry Powders in Rats, Journal of Pharmaceutical Sciences, 92, 938-950 (2003)
    
88. Denet A.R., Ucakar B. and Préat V.
    Transdermal delivery of timolol and atenolol using Electroporation and Iontophoresis in Combination : a Mechanistic Approach
    Pharmaceutical Research, 20 (12) : 1946-1951 (2003)
    
89. Denet A.R., Vanbever R.. and Préat V.
    Skin electroporation for transdermal and topical drug delivery
    Advanced Drug Delivery Review, 56 (5), 659-674 (2004)
    
90. Codrons V., Vanderbist F., Ucakar B., Préat V. and Vanbever R.
    Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone 1-34 from rat lungs, J. Pharm. Sci , 93(5), 1241-1252 (2004)
    
91. Lombry C., Marteleur A., Arras M., Lison D., Louahed J. , Renauld J.C., Préat V. and Vanbever R.
    Local and systemic immune responses to intratracheal instillation of antigen and DNA vaccines in mice.
    Pharmaceutical Research, 21(1) : 127-135 (2004)
    
92. Lombry C., Edwards, D.A., Préat V. and Vanbever R.
    Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules
    Am. J. Physiol. Lung Cell Mol. Physiol. 286 : L1002-L1008 (2004)
    
93. Bosquillon C., Préat V. and Vanbever R.
    Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats
    J. Controlled Release, 96, 233-244 (2004)
    
94. Bosquillon C., Rouxhet P.G., Ahimou F., Simon D., Culot C., Préat V., Vanbever R.
    Aerosolization properties, surface composition and physical state of spray-dried protein powders
    Journal of Controlled Release, 99, 357-367 (2004)
    
95. Ould Ouali L., Arien T., Rosenblatt J., Nathan A., Twaddle P., Matalenas T., Borgia M., Arnold S., Leroy D., Dinguizli M., Rouxhet L., Brewster M. and Préat V.
    Biodegradable self assembling PEG-copolymer as vehicle for poorly water soluble drugs
    Pharmaceutical Research, 21, 1581-1590 (2004)
    
96. Préat V.
    Noninvasive lithium monitoring
    Clinical Chemistry, 50, 1966-1967 (2004)
    
97. Mathy F.X., Lombry C., Verbeeck R.K., Préat V.
    Study of the Percutaneous penetration of flurbiprofen by cutaneous and subcutaneous microdialysis after iontophoretic delivery in rat
    Journal of Pharmaceutical Sciences, 94, 1, 144-152 (2005)
    
98. Latere Dwanlsa J.P., Dinguizli M., Préat V., Arien A., Brewster M.
    Qualitative prediction of solubilization of highly hydrophobic drugs in block copolymer micelles
    Journal of Controlled Release, 101, 366-368 (2005)
    
99. Ould-Ouali L., Noppe M., Langloix X., Willems B., Te Riele P., Timmerman P., Brewster M.E., Arien A., Préat
    Self assembling PEG-p(CL-co-TMC) compolymers for oral delivery of poorly water-soluble drugs : a case study with risperidone
    Journal of Controlled Release, 102, 657-668 (2005)
    
100. Musaji A., Meite M., Detalle L., Franquin S., Cormont F., Préat V., Izui S., Coutelier J.P.
     Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia
     Autoimmunity Reviews, 4, 247-252 (2005)
     
101. Mathy F.X., Ntivunwa, D., Verbeeck R.K., Préat V.
     Fluconazole distribution in rat dermis following intravenous and topical application : a microdialysis study
     Journal of Pharmaceutical Sciences, 94, 770-780 (2005)
     
102. des Rieux A., Ragnarsson E.G., Gullberg E., Préat V., Schneider Y.J., Artursson P.
     Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium
     European Journal of Pharmaceutical Sciences, 25, 455-465 (2005)
     
103. Pavselj N., Préat V., DNA electrotransfer into the skin usin a combination of one high- and one low-voltage pulse
     Journal of Controlled Release, 106, 407-415 (2005)
     
104. El-Azami-El-Idrissi M.; Franquin S., Day M.J., Mazza G., Elson C.J., Préat,V., Pfau C.J., Coutelier J.P.
     Distinct host-dependent pathogenic mechanisms leading to a similar clinical anemia after infection with lymphocytic choriomeningitis virus
     Exp.Biol.Med. (Maywood.), 230, 865-871 (2006)
     
105. Mathot F, Van Beijsterveldt L, Préat V, Brewster M, Arien AN
     Intestinal uptake and biodistribution of novel polymeric micelles after oral administration
     Journal of Controlled Release, 111:47-55 (2006)
     
106. Charlier N, Préat V, Gallez B
     Evaluation of lipid-based carrier systems and inclusion complexes of diethyldithiocarbamate-iron to trap nitric oxide in biological systems
     Magn. Res. Med, 55: 215-218 (2006)
     
107. Préat V, Roland-Marcelle N, Van den Abeele B
     Histoire de la pharmacie galénique: L'art de préparer les médicaments de Galien à nos jours.
     
108. Vandermeulen G, Rouxhet L, Arien A, Brewster ME, PréatV
     Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles
     International journal of Pharmaceutics, 309:234-240 (2006)
     
109. Beghein N, Rouxhet L, Dinguizli M, Brewster ME, Arien A, Préat V, Habib JL, Gallez B.
     Characterization of self-assembling copolymers in aqueous solutions using Electron Paramagnetic Resonance and Fluorescence spectroscopy
     Journal of Controlled Release, 117: 196-203 (2007)
     
110. des Rieux A, Fievez V, Momtaz M, Detrembleur C, Alonso-Sande M, Van Gelder J, Cauvin A, Schneider YJ, Préat V
     Helodermin-loaded nanoparticles: Characterization and transport across an in vitro model of the follicle-associated epithelium
     Journal of Controlled Release, 118: 294-302 (2007)
     
111. des Rieux A, Fievez V, Théate I, Mastd J, PréatV, Schneider YJ
     An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells
     Eur. J. Pharm. Sci., 30: 380-391 (2007)
     
112. Garinot M, Fievez V, Pourcelle V, Stoffelbach F, des Rieux A, Plapied L, Theate I, Freichels H, Jerôme C, Marchand Brynaert J, Schneider YJ, Préat V
     PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
     Journal of Controlled Release, 120: 195-204 (2007)
     
113. Latere Dwan'Isa JP, Rouxhet L, Preat V, Brewster M.E., Arien A
     Prediction of drug solubility in amphiphilic di-block copolymer micelles: the role of polymer-drug compatibility
     Pharmazie, 62- 499-504 (2007)
     
114. Mathot F, Schanck F, Van Bambeke F, Arien A, Noppe M, Brewster M, Préat V
     Passive diffusion of polymeric surfactants across lipid bilayers
     Journal of Controlled Release, 120, 79-87
     
115. Mathot F., des Rieux A, Ariën A, Schneider YJ, Brewster M, Préat V
     Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier
     Journal of Controlled Release, 124: 134-143
     
116. Pavselj N, Préat V, Miklavcic D
     A numerical model of skin electropermeabilization based on in vivo experiments,
     Ann.Biomed.Eng, 35: 2138-2144
     
117. Pourcelle V, Devouge S, Garinot M, Préat V, Marchand-Brynaert J.
     PCL-PEG-Based nanoparticles grafted with GRDGS peptide: preparation and surface analysis by XPS, Biomacromolecules, 8: 3977-3983
     
118. Rozet E, Wascotte V, Lecouturier N, Préat V, Dewé W, Boulanger B, Hubert P
     Improvement of the decision efficiency of the accuracy profile by means of a desirability function for analytical methods validation: application to a diacetyl-monoxime colorimetric assay used for the determination or urea in transdermal iontophoretic extracts,
     Analytica Chimica Acta, 591, 239-247 (2007)
     
119. Vandermeulen G, Staes E, Vanderhaeghen ML, Bureau M.F, Scherman D, Preat,V
     Optimisation of intradermal DNA electrotransfer for immunisation,
     Journal of Controlled Release, 124: 81-87 (2007)
     
120. Vroman, Mazza M, Fernandez M, Jérôme R, Préat V
     Copolymers of e-caprolactone and quaternized e-caprolactone as gene carriers,
     Journal of Controlled Release, 118: 136-144 (2007)
     
121. Vroman B, Ferreira I, Jerome C, Jerome R, Preat V
     PEGylated quaternized copolymer/DNA complexes for gene delivery,
     International Journal of Pharmaceutics, 344: 88-95 (2007)
     
122. Wascotte V, Delgado-Charro MB, Rozet E, Wallemacq P, Hubert P, Guy RH, Préat V,
     Monitoring of Urea and Potassium by Reverse Iontophoresis In Vitro,
     Pharmaceutical Research, 24, 1131-1137 (2007)
     
123. Wascotte V, Caspers P, de Sterke J, Jadoul M, Guy RH, Préat V
     Assessment of the "Skin Reservoir" of Urea by Confocal Raman Microspectroscopy and Reverse Iontophoresis in vivo,
     Pharmaceutical Research, 24: 1897-1901 (2007)
     
124. Herkenne C, Alberti I, Naik A, Kalia YN, Mathy FX, Préat V, Guy RH
     In vivo methods for the assessment of topical drug bioavailability, Pharmaceutical Research, 25: 87-103 (2008)

Chapter of books

1. Vanbever R. and Préat V.
   Transdermal drug delivery by skin electroporation in the rat
   in Electrically mediated delivery of molecules to cells, Jaroszeski M., Gilbert R. and Heller R., Human Press, p 457-471(1999)
   
2. Préat V. and Vanbever R.
   Topical delivery by iontophoresis
   in Handbook of cosmetic science and technology, Barel A., Maibach H. and Paye M. (Eds), Marcel Dekker (2001)
   
3. Préat V.
   Skin electroporation
   in Transdermal drug delivery, Guy R. and Hadgraft J. (Eds), Marcel Dekker, (2001)
   
4. Préat V., Vanbever R,
   Skin electroporation for transdermal and topical drug delivery in : J. Hadgraft and R.H. Guy (eds), Transdermal drug delivery, - developmental issues and research initiatives, Marcel Dekker, 2nd edition, pp 227-254 (2003)
   
5. Nathalie Dujardin, V. Préat
   Delivery of DNA to Skin Electroporation
   Methods in molecular Biology, vol. 245
   Gene delivery to Mammalian cells, volume 1 : nonviral gene transfer techniques
   Edited by William C. Heiser, Humana Press, Totowa, New Jersey, pp.215-226
   (2003)
   
6. Préat V, Wascotte V
   Topical delivery by iontophoresis in handbook of cosmetic science and technology, Second edition, ed. Paye M., Barel A., Maibach H. pp.189-200 (2006)
   
   

1. Polymeric microemulsions
   Année d'obtention : 2003
   Auteur(s) : Arien Albertina, Brewster Marcus, Nathan Aruna, Rosenblatt Joel, Ould-Ouali Louisa, Préat Véronique
   Numéro d'enregistrement : WO2003EP04368 20030424

Edited Review

Special issue “ Drug delivery by high voltage pulse application ”
Préat V. and Prausnitz M. (Eds)
Advanced Drug delivery Reviews, 35 n°1
1999